Ther Drug Monit 2016 Apr;38(2):143-69
*Klinikum Stuttgart, Zentralinstitut für Klinische Chemie und Laboratoriumsmedizin, Stuttgart, Germany; †Department of Internal Medicine, Division of Nephrology and Renal Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; ‡Analytical Services International, London, United Kingdom; §Pharmacology, APHP, Hôpital Européen G Pompidou, Paris Descartes University, Paris, France; Departments of ¶Internal Medicine and ‖Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; **Clinical Pharmacology Unit, Institute of Cardiology, Warsaw, Poland; ††Pharmacology and Toxicology Laboratory, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, University of Barcelona, Spain; ‡‡Medizinische Klinik mit Schwerpunkt Nephrologie, Charité Universitätsmedizin Berlin, Berlin, Germany; §§Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany; ¶¶Hepatobiliary Surgery and Liver Transplantation Unit, University of Pisa Medical Hospital, Pisa, Italy; ‖‖Pharmacology and Toxicology Laboratory (CDB), CIBERehd, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Spain; ***Department of Pharmacy, Kyushu University Hospital, Kyushu University, Fukuoka, Japan; †††Department of Clinical Pharmacology & Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; ‡‡‡Risch Laboratories Group, Schaan, Principality of Liechtenstein; §§§UMR 850 INSERM, University of Limoges, CHU Limoges, Limoges, France; ¶¶¶Department of Clinical Pharmacology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany; ‖‖‖Toxicology and Drug Monitoring Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, College of Medicine, Rochester, MN; ****Clinical Chemistry Department, Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium;